Integrative hedonic and homeostatic food intake regulation by the central nervous system: insights from neuroimaging
Plain English With Derek Thompson The Future of GLP-1 Drugs and AI Medicine, With Eli Lilly CEO David Ricks Hosts About the episode The GLP-1 drug revolution has taken the medicine world by storm
First, it provides continuous GLP-1 receptor engagement throughout the day, including overnight, ensuring that the appetite-suppressing, glucose-regulating, and gastric-emptying effects of GLP-1 receptor activation are maintained without interruption
This dual effect makes it a promising candidate for muscle growth and metabolic improvement, especially in populations with lipodystrophy (a group of disorders that affect how the body stores fat) or sarcopenia (age-related muscle loss) (15)
Yes, GIP medications can cause side effects in some people